Kelyniam Global has received FDA clearance for its Fusion brand of cranial and craniofacial implants, the first new product of its kind in eight years.
The implants are made from a combination of biphasic calcium phosphate with polyether ether ketone, and is designed to help bone grow into the implant, according to a Sept. 18 news release.
Kelyniam said the implants can be designed and shipped to surgeons within 24 to 48 hours, helping patients who need surgery after trauma, tumor removal or congenital skull conditions. The product adds to the company’s regenerative implant line, which also includes hydroxyapatite and Osteopore brand implants.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
